Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doris Barcellona

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
International Journal of Molecular Sciences|September 27, 2025
Clinical and Genetic Heterogeneity of Factor XI Deficiency: Insights from a Southern Italian CohortRosa Santacroce, Giovanna D'Andrea, Giovanni Luca Tiscia, et al.
Clinical and Experimental Medicine|May 25, 2022
Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by OmalizumabMarina Di Pino, Maria Filomena Ruberto, Giulia Costanzo, et al.
International Journal of Laboratory Hematology|December 11, 2024
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid RegistryAnna Aiello, Luca Sarti, Gilda Sandri, et al.
Open Heart|September 20, 2018
Risk of reoperation in bioprosthetic valve patients with indication for long-term anticoagulation. Results from the observational retrospective multicentre PLECTRUM studyDaniela Poli, Emilia Antonucci, Vittorio Pengo, et al.
Internal and Emergency Medicine|June 16, 2026
Thrombocytopenia in carriers and patients with antiphospholipid syndrome: insights from the nationwide START-APS registryFrancesco Del Sole, Tommaso Bucci, Danilo Menichelli, et al.
European Journal of Internal Medicine|June 12, 2020
Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACsDaniela Poli, Emilia Antonucci, Elisa Vignini, et al.
Journal of Thrombosis and Haemostasis : JTH|October 31, 2020
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closureVittorio Pengo, Ariela Hoxha, Laura Andreoli, et al.
Journal of Public Health Research|May 26, 2021
Clot characterization by multidisciplinary approach: biochemical and imaging parameters in a hypocoagulative setting. A pilot studyFrancesco Marongiu, Dimitrios Marco Ntoukas, Luigi Barberini, et al.
Human Reproduction (Oxford, England)|July 1, 2021
Findings from a multicentre, observational study on reproductive outcomes in women with unexplained recurrent pregnancy loss: the OTTILIA registryElvira Grandone, Giovanni L Tiscia, Mario Mastroianno, et al.
Blood|July 14, 2018
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndromeVittorio Pengo, Gentian Denas, Giacomo Zoppellaro, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
International Journal of Molecular Sciences|September 27, 2025
Clinical and Genetic Heterogeneity of Factor XI Deficiency: Insights from a Southern Italian CohortRosa Santacroce, Giovanna D'Andrea, Giovanni Luca Tiscia, et al.
Clinical and Experimental Medicine|May 25, 2022
Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by OmalizumabMarina Di Pino, Maria Filomena Ruberto, Giulia Costanzo, et al.
International Journal of Laboratory Hematology|December 11, 2024
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid RegistryAnna Aiello, Luca Sarti, Gilda Sandri, et al.
Open Heart|September 20, 2018
Risk of reoperation in bioprosthetic valve patients with indication for long-term anticoagulation. Results from the observational retrospective multicentre PLECTRUM studyDaniela Poli, Emilia Antonucci, Vittorio Pengo, et al.
Internal and Emergency Medicine|June 16, 2026
Thrombocytopenia in carriers and patients with antiphospholipid syndrome: insights from the nationwide START-APS registryFrancesco Del Sole, Tommaso Bucci, Danilo Menichelli, et al.
European Journal of Internal Medicine|June 12, 2020
Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACsDaniela Poli, Emilia Antonucci, Elisa Vignini, et al.
Journal of Thrombosis and Haemostasis : JTH|October 31, 2020
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closureVittorio Pengo, Ariela Hoxha, Laura Andreoli, et al.
Journal of Public Health Research|May 26, 2021
Clot characterization by multidisciplinary approach: biochemical and imaging parameters in a hypocoagulative setting. A pilot studyFrancesco Marongiu, Dimitrios Marco Ntoukas, Luigi Barberini, et al.
Human Reproduction (Oxford, England)|July 1, 2021
Findings from a multicentre, observational study on reproductive outcomes in women with unexplained recurrent pregnancy loss: the OTTILIA registryElvira Grandone, Giovanni L Tiscia, Mario Mastroianno, et al.
Blood|July 14, 2018
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndromeVittorio Pengo, Gentian Denas, Giacomo Zoppellaro, et al.
Pageof 6